Neo approaches to cancer vaccines

Science

Volumn 348, Issue 6236, 2015, Pages 760-761

  Delamarre, Lélia ^a   Mellman, Ira ^a   Yadav, Mahesh ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CANCER VACCINE; PEPTIDE VACCINE; PROGRAMMED DEATH 1 RECEPTOR; HLA A2 ANTIGEN; TUMOR ANTIGEN;

CANCER; DISEASE TREATMENT; IMMUNIZATION; MUTATION; VACCINATION;

CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR REGRESSION; ACTIVE IMMUNIZATION; IMMUNOLOGY; PROCEDURES; SKIN NEOPLASMS; TRANSPLANTATION;

ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY, ACTIVE; MELANOMA; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 84929379430     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aab3465     Document Type: Review

References (12)

1. P. Sharma, J. P. Allison, Science 348, 56 (2015).
2. T. N. Schumacher, R. D. Schreiber, Science 348, 69 (2015).
3. B. M. Carreno et al., Science 348, 803 (2015).
4. N. A. Rizvi et al., Science 348, 124 (2015).
5. M. S. Rooney et al., Cell 160, 48 (2015).
6. A. Snyder et al., N. Engl. J. Med. 371, 2189 (2014).
7. M. M. Gubin et al., Nature 515, 577 (2014).
8. M. Yadav et al., Nature 515, 572 (2014).
9. K. Palucka, J. Banchereau, Immunity 39, 38 (2013).
10. S. Kreiter et al., Nature 520, 692 (2015).
11. C. Linnemann et al., Nat. Med. 21, 81 (2015).
12. E. Tran et al., Science 344, 641 (2014).